Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial towards patient enrolment, with key…
Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market after expanding its licensing agreement…
Shares in drug development company Actinogen Medical (ASX: ACW) have plummeted following the results release of their Phase 2a clinical…
With mixed quarter results for the June quarter, Holista Colltech (ASX: HCT) - a research-driven biotech company, is trying to…
A new drug seeking to treat irritability associated with Autism Spectrum Disorder (ASD) could soon be making its way to…
Biotechnology company Emyria (ASX: EMD), which develops treatments for mental health and neurological conditions, has newly inaugurated its treatment facility…